| AVUSX | VTSAX | AVUSX / VTSAX | |
| Total Expense Ratio | 0.15 | 0.04 | 375% |
| Annual Report Gross Expense Ratio | 0.15 | 0.04 | 375% |
| Fund Existence | 7 years | 26 years | - |
| Gain YTD | 17.765 | 12.874 | 138% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000000 | 3000 | 166,667% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 719M | 2.29T | 0% |
| Annual Yield % from dividends | 0.98 | 1.05 | 94% |
| Returns for 1 year | 25.38 | 21.03 | 121% |
| Returns for 3 years | 78.26 | 74.30 | 105% |
| Returns for 5 years | 79.22 | 66.56 | 119% |
| Returns for 10 years | N/A | 249.88 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SHPAX | 23.98 | 0.24 | +1.01% |
| Saratoga Health & Biotechnology A | |||
| GQJIX | 12.86 | 0.08 | +0.63% |
| GQG Partners Intl Qual Val Fd Ins | |||
| OEGYX | 38.56 | 0.19 | +0.50% |
| Invesco Discovery Mid Cap Growth Y | |||
| GRMSX | 34.26 | 0.15 | +0.44% |
| Nationwide S&P 500 Index Svc | |||
| TNXIX | 23.19 | 0.09 | +0.41% |
| 1290 Avantis U.S. Large Cap Growth I | |||